Sensodyne has been asked to stop advertising in India.
The Central Consumer Protection Authority CCPA has issued an arrange requiring GlaxoSmithKline; (GSK) Buyer Healthcare Ltd to halt promoting Sensodyne items in India due to infringement of the law. The Central Consumer Protection Authority; (CCPA) has moreover requested Naaptol Online Shopping Ltd to pay a punishment of Rs 10 lakh for deluding; advertisements and unjustifiable exchange practices.
The Shopper Undertakings Service said in a explanation on Wednesday that the CCPA took suo moto cognizance; of the matter and also issued orders against GlaxoSmithKline (GSK) Customer Healthcare; on January 27 and Naaptol on February 2 this year.
The CCPA has ordered GlaxoSmithKline (GSK) Consumer Healthcare to stop advertising Sensodyne in India; within seven days of the order’s issue because the ads featured dentists practicing outside of India supporting the products.
Given that dentists in India are prohibit from publicly endorsing any product or drug; the CCPA stated that GSK Consumer Healthcare “cannot be allowed; to evade the law in existence in India and also exhibit foreign dentists to exploit consumer apprehension over dental discomfort.”
“As a result, advertisements of Sensodyne goods in India that include endorsements from dentists practicing outside; of India constitute as’misleading advertisement’ under Section 2 (28) of the Consumer Protection Act, 2019,” according to the ruling.
The CCPA has also ordered the Director General (Investigation) to submit; a report within 15 days after investigating the claims “recommended by dentists worldwide,” “world’s no.1 sensitivity toothpaste,”; and also clinically proven relief, works in 60 seconds,” as well as the company’s supporting documents.
see also: Shikhar Dhawan and Shreyas Iyer are back in training after recovering from COVID-19 ahead of the second ODI against West Indies.
“We affirm that the CCPA’s order has been receive. While we investigate further, we’d like to make it clear that our marketing; efforts adhere to all applicable laws and industry standards. In a statement, a spokeswoman for GSK Consumer Healthcare said; “We are a responsible and compliant firm commit to the welfare of its consumers.”
The CCPA issued an order against Naaptol Online Shopping Ltd in another suo moto case; ordering the company to stop deceptive ads for “Set of 2 Gold Jewelry,” “Magnetic Knee Support,” and “Acupressure Yoga Slippers.”
The CCPA also fined Naaptol Rs 10 lakh, claiming that its deceptive marketing impacted; a large number of consumers because the company operates a 24×7 channel; and broadcasts in multiple languages on a regular basis across the country.
According to the order, Naaptol must explicitly state in episodes offering products; for sale to consumers that it is a recorded episode that does not reflect; the current inventory position of the production.
It also ordered Naaptol to stop using any techniques that create “artificial scarcity” of products; such as claiming that a product is only available today if it will be accessible within the next 30 days.
The corporation has urged to make it clear on any promotional channel; or platform that it is a pre-recorded show.
read more: Betis leads Rayo in the Copa semifinals thanks to a goal from William Carvalho.
The CCPA has also ordered Naaptol to resolve all complaints filed between May 2021; and January 2022 and provide a report within 15 days of receiving them.
According to data from the National Consumer Helpline; 399 complaints were file against Naaptol between June 2021 and January 25 this year.
[…] read more: Sensodyne has been asked to stop advertising in India. […]